The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

Feb. 27, 2023
Applicant:

Sinai Health System;

Inventors:

Andras Nagy, Toronto, CA;

Jeffrey Harding, Toronto, CA;

Kristina Nagy, Toronto, CA;

Assignee:

Sinai Health System, Toronto, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0735 (2010.01); A61K 35/545 (2015.01); A61K 45/06 (2006.01); A61P 1/16 (2006.01); A61P 3/00 (2006.01); A61P 3/10 (2006.01); A61P 7/04 (2006.01); A61P 9/10 (2006.01); A61P 19/02 (2006.01); A61P 25/16 (2006.01); A61P 27/02 (2006.01); A61P 37/06 (2006.01); C07K 14/47 (2006.01); C07K 14/52 (2006.01); C07K 14/705 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
A61K 35/545 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2018.01); A61P 3/00 (2018.01); A61P 3/10 (2018.01); A61P 7/04 (2018.01); A61P 9/10 (2018.01); A61P 19/02 (2018.01); A61P 25/16 (2018.01); A61P 27/02 (2018.01); A61P 37/06 (2018.01); C07K 14/47 (2013.01); C07K 14/521 (2013.01); C07K 14/70503 (2013.01); C07K 14/70532 (2013.01); C07K 14/70575 (2013.01); C12N 5/0606 (2013.01); C12N 15/09 (2013.01); C12N 2510/00 (2013.01);
Abstract

A cell genetically modified to comprise at least one mechanism for providing a local immunosuppression at a transplant site when transplanted in an allogeneic host is, and methods for making and using the same is provided. The cell comprises a set of transgenes, each transgene encoding a gene product that is cytoplasmic, membrane bound, or local acting, and whose function is one or more of: to mitigate antigen presenting cell activation and function; to mitigate graft attacking leukocyte activity or cytolytic function; to mitigate macrophage cytolytic function and phagocytosis of allograft cells; to induce apoptosis in graft attacking leukocytes; to mitigate local inflammatory proteins; and to protect against leukocyte-mediated apoptosis.


Find Patent Forward Citations

Nagy, Andras. (2024). Allograft tolerance without the need for systemic immune suppression (U.S. Patent No. 12178835). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12178835

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…